VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+4.9%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$265M
AUM Growth
+$37.5M
(+17%)
Cap. Flow
+$31.7M
Cap. Flow
% of AUM
11.98%
Top 10 Holdings %
Top 10 Hldgs %
9.25%
Holding
421
New
24
Increased
206
Reduced
145
Closed
45
Top Buys
| 1 |
DT Midstream
DTM
|
$1.86M |
| 2 |
ScottsMiracle-Gro
SMG
|
$878K |
| 3 |
Valero Energy
VLO
|
$790K |
| 4 |
FMC
FMC
|
$775K |
| 5 |
Delek US
DK
|
$761K |
Top Sells
| 1 |
COR
Coresite Realty Corporation
COR
|
$1.67M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$601K |
| 3 |
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
|
$551K |
| 4 |
Travere Therapeutics
TVTX
|
$479K |
| 5 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$448K |
Sector Composition
| 1 | Real Estate | 22.39% |
| 2 | Healthcare | 18.38% |
| 3 | Energy | 15.88% |
| 4 | Materials | 14.07% |
| 5 | Utilities | 13.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CERE
251
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $179K | 0.07% |
5,525
-10,142
| -65% | -$329K |
|
252
AbCellera Biologics
ABCL
$1.24B
| $178K | 0.07% |
12,482
+3,818
| +44% | +$54.4K |
|
253
Arcturus Therapeutics
ARCT
$455M
| $178K | 0.07% |
4,803
-1,110
| -19% | -$41.1K |
|
254
Fulcrum Therapeutics
FULC
$372M
| $178K | 0.07% |
+10,059
| New | +$178K |
|
255
Praxis Precision Medicines
PRAX
$970M
| $178K | 0.07% |
602
-82
| -12% | -$24.2K |
|
256
Cogent Biosciences
COGT
$1.81B
| $177K | 0.07% |
20,610
-2,725
| -12% | -$23.4K |
|
|
CMRX
257
DELISTED
Chimerix, Inc.
CMRX
| $177K | 0.07% |
27,514
+2,361
| +9% | +$15.2K |
|
|
ADAP
258
Adaptimmune Therapeutics
ADAP
$13.5M
| $176K | 0.07% |
46,931
-419
| -0.9% | -$1.57K |
|
259
Curis
CRIS
$21.4M
| $176K | 0.07% |
1,846
+529
| +40% | +$50.4K |
|
260
ImmunityBio
IBRX
$2.26B
| $176K | 0.07% |
28,969
+14,725
| +103% | +$89.5K |
|
261
Repare Therapeutics
RPTX
$72.6M
| $176K | 0.07% |
8,355
+1,873
| +29% | +$39.5K |
|
|
MYOV
262
DELISTED
Myovant Sciences Ltd.
MYOV
| $176K | 0.07% |
11,289
+1,534
| +16% | +$23.9K |
|
263
Akero Therapeutics
AKRO
$3.52B
| $175K | 0.07% |
8,266
+1,120
| +16% | +$23.7K |
|
264
Iovance Biotherapeutics
IOVA
$796M
| $175K | 0.07% |
9,182
+281
| +3% | +$5.36K |
|
|
MORF
265
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $175K | 0.07% |
3,693
+420
| +13% | +$19.9K |
|
266
Nurix Therapeutics
NRIX
$697M
| $174K | 0.07% |
6,010
-1,183
| -16% | -$34.3K |
|
|
MRTX
267
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $174K | 0.07% |
1,183
-66
| -5% | -$9.71K |
|
268
Compugen
CGEN
$132M
| $173K | 0.07% |
40,161
+15,182
| +61% | +$65.4K |
|
269
Dynavax Technologies
DVAX
$1.17B
| $173K | 0.07% |
12,277
-11,295
| -48% | -$159K |
|
270
Precigen
PGEN
$1.36B
| $173K | 0.07% |
46,531
+16,382
| +54% | +$60.9K |
|
271
Rhythm Pharmaceuticals
RYTM
$6.95B
| $173K | 0.07% |
17,290
+7,061
| +69% | +$70.7K |
|
272
FibroGen
FGEN
$45.7M
| $172K | 0.07% |
489
+160
| +49% | +$56.3K |
|
273
Prelude Therapeutics
PRLD
$64.5M
| $172K | 0.07% |
13,815
+7,523
| +120% | +$93.7K |
|
|
VBIV
274
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $172K | 0.07% |
+2,444
| New | +$172K |
|
|
KNTE
275
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $172K | 0.07% |
+9,725
| New | +$172K |
|